Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019 (CROSBI ID 283127)
Prilog u časopisu | kratko priopćenje | međunarodna recenzija
Podaci o odgovornosti
Kissling, Esther ; …. ; Filipovic, Sanja Kurecic ; Visekruna-Vucina, Vesna ; Novosel, Iva Pem ; Lovric, Zvjezdana ; Petrovic, Goranka ; Drazenovic, VladimirVince, Adriana ; Topic, Antea ; Mihalic, Jelena Budimir ; Huljev, Eva ; Luksic, Boris ; Karabuva, Svjetlana ; Cikes, Mihaela ; … ; Zambon, Maria
European IVE Grp
engleski
Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019
Influenza A(H1N1)pdm09 and A(H3N2) viruses both circulated in Europe in October 2018–January 2019. Interim results from six studies indicate that 2018/19 influenza vaccine effectiveness (VE) estimates among all ages in primary care was 32–43% against influenza A ; higher against A(H1N1)pdm09 and lower against A(H3N2). Among hospitalised older adults, VE estimates were 34–38% against influenza A and slightly lower against A(H1N1)pdm09. Influenza vaccination is of continued benefit during the ongoing 2018/19 influenza season.
Europe ; influenza ; multicentre study ; test-negative design ; vaccination ; vaccine effectiveness ; vaccines and immunisation.
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
24 (8)
2019.
1900121
23
objavljeno
1025-496X
1560-7917
10.2807/1560-7917.ES.2019.24.1900121
Povezanost rada
Kliničke medicinske znanosti
